NYSE:CNC 2D Graph Positive*InvestingPro Notes
Management has been aggressively buying back shares
High shareholder yield
Trading at a low P/E ratio relative to near-term earnings growth
Prominent player in the Healthcare Providers & Services industry
**Analyst Targets
17 analysts
$79,39
***Investing Models
3 models
$75,58
Metric Name Value
Market Cap (Adjusted)
30.711 B
Price / Book
1.1x
Avg Price / Book (10y)
2.3x
Predicted Price / Book
1.5x
P/E Ratio
10.0x
Avg P/E Ratio (10y)
25.6x
EV / EBITA
3.0x
Avg EV / EBITDA (10y)
6.8x
Market Cap / LTM Revenue
0.2x
Revenue Growth
4.9%
Revenue Growth Forecast
13.9%
Revenue
146.2 B
Net Income to Company
3.053 B
EBITDA
5.919 B
EBITDA Growth
-7.9%
EBITDA CAGR (5y)
18.3%
EBITDA Growth Forecast
-30.4%
Common Equity
27.307 B
Total Debt / Total Capital
36.4%
Current Ratio
1.1x
Dividend Yield
0.0%
Operating Income Trend Score
87.5%
Total Debt Trend Score
0.0%
Common Equity CAGR (5y)
18.8%
🎁Great Opportunity! Be one step ahead in the world of investment with Investing Pro+! Now with a channel-specific +15% discount and a total of 70%, don't miss this opportunity! 📈
CODE: sepethissepro
We wish you success in your investments.
